Highly respected institutions all over the world combine medical care with research in order to bring the best and latest treatment options to their patients. This means patients would not have to travel to Institutions such as the University of Miami, Cleveland Clinic, Shands Hospital, Johns Hopkins or NIH (National Institute of Health) for novel (new) therapeutic agents. His continuous involvement in research and leadership led to the creation of another organization called Triple O Research Institute P.A. in 2006. This new entity was established solely for Phase one to Phase four clinical trials. Dr. Osiyemi has partnered with many pharmaceutical industries to provide many novel therapies and has published several articles in major medical journals.